 |
|
The Effect of Buspirone on Prolactin and Growth Hormone Secretion in Man
Herbert Y. Meltzer, MD;
Rachel Flemming, PhD;
Alan Robertson, MD
Arch Gen Psychiatry. 1983;40(10):1099-1102.
Abstract
• Buspirone hydrochloride, a compound with novel chemical structure, has been reported to be anxiolytic in man. Its mechanism of action as an anxiolytic is unknown, but preclinical studies have shown that it produces effects consistent with both a dopamine agonist and antagonist. In man, buspirone hydrochloride at doses of 30,60, and 90 mg orally significantly elevated plasma prolactin (PRL) and growth hormone (GH) concentrations. The apparent increase in PRL secretion was dose dependent, but that of GH was not. The increase in PRL secretion could be due to a dopamine antagonist effect at the pituitary gland. A dopamine agonist action at hypothalamic dopamine receptors could account for the increase in GH secretion. Benzodiazepine anxiolytic drugs also increase serum GH levels in man, by a mechanism that has not been clearly established. It may be that buspirone and benzodiazepine drugs stimulate GH secretion by a common mechanism that is related to their anxiolytic actions.
Author Affiliations
From the Department of Psychiatry, University of Chicago, Pritzker School of Medicine (Drs Meltzer and Robertson), and the Illinois State Psychiatric Institute (Drs Meltzer, Flemming, and Robertson), Chicago.
Footnotes
Accepted for publication Oct 5, 1982.
Reprint requests to University of Chicago, Pritzker School of Medicine, 950 E 59th St, Chicago, IL 60637 (Dr Meltzer).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Tardive Dyskinesia Predicts Prolactin Response to Buspirone Challenge in People With Schizophrenia
Shim et al.
J. Neuropsychiatry Clin. Neurosi. 2005;17:221-226.
ABSTRACT
| FULL TEXT
Menstrual cycle effects on the action of buspirone on food intake in healthy female volunteers
Goodall et al.
J Psychopharmacol 1995;9:307-312.
ABSTRACT
BAP/SKB Young Psychopharmacologist Award Towards a neuroendocrinology of obsessive-compulsive disorder
Lucey
J Psychopharmacol 1994;8:250-257.
ABSTRACT
Acute exacerbation of psychosis with buspirone?
Pantelis and Barnes
J Psychopharmacol 1993;7:295-300.
ABSTRACT
Prolactin and Cortisol Responses to MK-212, a Serotonin Agonist, in Obsessive-Compulsive Disorder
Bastani et al.
Arch Gen Psychiatry 1990;47:833-839.
ABSTRACT
Preliminary Evidence of a Serotonin (5-HT-1-Like) Component to the Prolactin Response to Buspirone Challenge in Humans
Coccaro et al.
Arch Gen Psychiatry 1990;47:594-595.
ABSTRACT
|
